Skip to main content

Table 1 Baseline characteristics of eligible case-control studies

From: Association between GABRG2 rs211037 polymorphism and febrile seizures: a meta-analysis

Author Year Country/Region Ethnicity Genotyping method Control Matched control HWE Total Case Control
Abdel 2012 Egypt Mixed PCR-RFLP Healthy Yes Yes 220 100 120
Balan 2013 India Mixed AS-PCR MTLE-HS without FS Yes Yes 203 138 65
Butila 2018 Romania Caucasian PCR-RFLP Patients No Yes 207 54 153
Chou 2003 Mainland of China Asian PCR-RFLP Healthy No Yes 186 103 83
Haerian 2015 Hong Kong, China Asian MassARRAY Healthy Yes Yes 2894 50 2844
Haerian 2015 Malaysia (Chinese) Asian MassARRAY Healthy Yes Yes 494 17 477
Haerian 2015 Malaysia (Malay) Asian MassARRAY Healthy Yes Yes 370 11 359
Haerian 2015 Malaysia (Indian) Asian MassARRAY Healthy Yes Yes 244 2 242
Kinirons A 2006 United Kingdom Caucasian tSNP Healthy No Yes 414 84 330
Kinirons B 2006 Ireland Caucasian tSNP Healthy No Yes 363 80 283
Nakayama 2003 Japan Asian DHPLC Healthy No Yes 200 94 106
Ponnala 2012 India Mixed PCR-RFLP Healthy or patients No Yes 186 86 100
  1. AS-PCR Allele-specific polymerase chain reaction, DHPLC denaturing high-performance liquid chromatography, MassARRAY matrixassisted laser desorption/ionization time of flight mass spectrometry, MTLE-HS mesial temporal lobe epilepsy with hippocampal sclerosis, NA not available, PCR-RFLP polymerase chain reaction-restriction fragment length polymorphism, RT-PCR reverse transcription- polymerase chain reaction, tSNP a tagging single nucleotide polymorphism